Twist Bioscience Stock (NASDAQ:TWST)

Forecast Revenue Ownership Financials Chart Transcripts

Previous Close

$43.62

52W Range

$27.41 - $60.90

50D Avg

$45.14

200D Avg

$43.66

Market Cap

$2.85B

Avg Vol (3M)

$747.80K

Beta

1.78

Div Yield

TWST Company Profile

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

919

IPO Date

Oct 31, 2018

Website

TWST Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Sep 24	Sep 23	Sep 22
Oligo Pools	$16.91M	$14.49M	$12.42M
Synthetic Genes	$92.68M	$73.54M	$61.51M
Antibody Discovery	$20.33M	$23.17M	$24.17M
Dna And Biopharma Libraries	$13.93M	$10.20M	$6.15M
Ngs Tools	$169.13M	$123.71M	$99.31M

Fiscal year ends in Sep 24 | Currency in USD

TWST Financial Summary

	Sep 24	Sep 23	Sep 22
Revenue	$312.97M	$245.11M	$203.56M
Operating Income	$-220.83M	$-217.16M	$-249.02M
Net Income	$-208.73M	$-204.62M	$-217.86M
EBITDA	$-220.83M	$-174.15M	$-191.55M
Basic EPS	$-3.60	$-3.60	$-4.04
Diluted EPS	$-3.60	$-3.60	$-4.04

Fiscal year ends in Sep 24 | Currency in USD

Latest Earnings Call Transcripts

Q4 24Nov 18, 24 | 11:31 AM

Q3 24Aug 02, 24 | 2:37 PM

Q2 24May 02, 24 | 12:00 AM

Peer Comparison

Ticker	Company
PSNL	Personalis, Inc.
TMO	Thermo Fisher Scientific Inc.
NTRA	Natera, Inc.
ICLR	ICON Public Limited Company
CSTL	Castle Biosciences, Inc.
MTD	Mettler-Toledo International Inc.
GH	Guardant Health, Inc.
IQV	IQVIA Holdings Inc.
DHR	Danaher Corporation
CDNA	CareDx, Inc
A	Agilent Technologies, Inc.
ILMN	Illumina, Inc.
WAT	Waters Corporation
EXAS	Exact Sciences Corporation